Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · IEX Real-Time Price · USD
0.822
-0.098 (-10.63%)
At close: Jul 19, 2024, 4:00 PM
0.858
+0.036 (4.33%)
Pre-market: Jul 22, 2024, 7:07 AM EDT
Hoth Therapeutics Stock Forecast
HOTH's stock price has decreased by -68.25% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Hoth Therapeutics stock have an average target of 6.17, with a low estimate of 4.00 and a high estimate of 7.50. The average target predicts an increase of 650.43% from the current stock price of 0.82.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HOTH stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +386.50% | Jul 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +386.50% | Apr 5, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $6.5 → $7 | Strong Buy | Maintains | $6.5 → $7 | +751.37% | Apr 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +386.50% | Feb 5, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $12 → $7.5 | Strong Buy | Maintains | $12 → $7.5 | +812.19% | Sep 14, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.81
from -2.30
EPS Next Year
-1.16
from -1.81
Revenue Forecast
| Revenue | 2024 | 2025 | 2027 | 2028 |
|---|---|---|---|---|
| High | n/a | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a | n/a |
| Low | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -1.73 | -1.20 |
| Avg | -1.81 | -1.16 |
| Low | -1.86 | -1.12 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.